DECIBEL THERAPEUTICS, INC.
Profile
Company Names
DECIBEL THERAPEUTICS, INC.
Addresses
1325 BOYLSTON STREET, SUITE 500, BOSTON, MA 02215
215 FIRST STREET, SUITE 430, CAMBRIDGE, MA 02142
29 NEWBURY STREET, BOSTON, MA 02116
Phone Numbers
617-370-8701
617-585-2000
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$87,132,651.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-11-02
$54,800,067.00
$82,199,983.00
$27,399,916.00
Equity
1
2015-10-13
$32,332,584.00
$57,758,734.00
$25,426,150.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROGER
BROWN
DIRECTOR
JENS
ECKSTEIN
DIRECTOR
NEIL
EXTER
DIRECTOR
SEVENTH SENSE BIOSYSTEMS, INC.
| CORIDEA NC1, INC.
| CYTOMX THERAPEUTICS, INC.
| ELEMENT SCIENCE, INC.
| RHYTHM METABOLIC, INC.
| RHYTHM PHARMACEUTICALS, INC.
| GOLDFINCH BIOPHARMA, INC.
| PLIANT THERAPEUTICS, INC.
| THIRD ROCK VENTURES V, L.P.
| REVOLUTION MEDICINES, INC.
| GOLDFINCH BIO, INC.
| CEDILLA THERAPEUTICS, INC.
| DECIBEL THERAPEUTICS, INC.
| THIRD ROCK VENTURES VI, L.P.
ELISABETH
LEIDERMAN
EXECUTIVE OFFICER
CRAIG
MUIR
DIRECTOR
ANTHONY
PHILIPPAKIS
DIRECTOR
CHRISTINE
A.
POON
DIRECTOR
GEORGE
SCANGOS
DIRECTOR
MICHAEL
SOLOMON
EXECUTIVE OFFICER
KEVIN
STARR
EXECUTIVE OFFICER, DIRECTOR
PETER
A.
THOMPSON
DIRECTOR
RESPONSE BIOMEDICAL CORP
| SILVERBACK THERAPEUTICS, INC.
| DECIBEL THERAPEUTICS, INC.
| RECODE THERAPEUTICS, INC.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
